Analysts’ Opinions Are Mixed on These Healthcare Stocks: Teladoc (TDOC) and Boston Scientific (BSX)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC) and Boston Scientific (BSX).
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Teladoc (TDOC)
In a report released today, Ryan Daniels from William Blair reiterated a Hold rating on Teladoc. The company’s shares closed last Wednesday at $9.18.
According to TipRanks.com, Daniels is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Teladoc with a $7.70 average price target, implying a -17.8% downside from current levels. In a report issued on July 24, Citi also maintained a Hold rating on the stock with a $11.00 price target.
See the top stocks recommended by analysts >>
Boston Scientific (BSX)
TD Cowen analyst Josh Jennings maintained a Buy rating on Boston Scientific today and set a price target of $56.00. The company’s shares closed last Wednesday at $46.04.
According to TipRanks.com, Jennings is a 3-star analyst with an average return of
Currently, the analyst consensus on Boston Scientific is a Strong Buy with an average price target of $68.42, which is a 60.3% upside from current levels. In a report issued on July 14, TipRanks – DeepSeek also upgraded the stock to Buy with a $49.00 price target.
Read More on TDOC:
